Techno Medica Co., Ltd.(JP:6678)
¥2,146.00-38.00 (-1.74%)
JP:6678
Techno Medica Co., Ltd. financials statements
¥2,146.00
At close:-38.00 (-1.74%)
Want to see JP:6678 full AI Analyst Report?
Techno Medica Co., Ltd. (6678) Ratios
0 Followers
Techno Medica Co., Ltd. Ratios
JP:6678's free cash flow for Q2 2026 was ¥0.00. For the 2026 fiscal year, JP:6678's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.09 | 4.79 | 4.49 | 6.16 | 6.26 |
| Quick Ratio | 4.35 | 3.99 | 3.85 | 5.49 | 5.80 |
| Cash Ratio | 2.91 | 2.77 | 2.56 | 4.18 | 4.38 |
| Solvency Ratio | 0.33 | 0.31 | 0.40 | 0.41 | 0.48 |
| Operating Cash Flow Ratio | 0.36 | 0.30 | 0.34 | 0.32 | 0.78 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | ¥ 12.14B | ¥ 12.13B | ¥ 11.47B | ¥ 14.25B | ¥ 13.61B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.25 | 1.25 | 1.26 | 1.19 | 1.18 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | -5.10 | -6.47 | -4.40 | -6.69 | -5.90 |
| Profitability Margins | |||||
| Gross Profit Margin | 46.66% | 49.23% | 50.10% | 49.43% | 49.67% |
| EBIT Margin | 14.85% | 13.13% | 17.89% | 17.61% | 19.08% |
| EBITDA Margin | 15.67% | 14.13% | 18.98% | 18.76% | 20.13% |
| Operating Profit Margin | 14.85% | 13.13% | 17.89% | 17.61% | 19.20% |
| Pretax Profit Margin | 13.57% | 13.32% | 18.09% | 17.78% | 19.08% |
| Net Profit Margin | 9.53% | 10.14% | 13.11% | 12.28% | 13.21% |
| Continuous Operations Profit Margin | 9.53% | 10.14% | 13.11% | 12.28% | 13.21% |
| Net Income Per EBT | 70.22% | 76.12% | 72.46% | 69.08% | 69.22% |
| EBT Per EBIT | 91.42% | 101.48% | 101.11% | 100.99% | 99.42% |
| Return on Assets (ROA) | 5.96% | 5.60% | 7.73% | 5.92% | 6.92% |
| Return on Equity (ROE) | 7.43% | 6.98% | 9.76% | 7.02% | 8.19% |
| Return on Capital Employed (ROCE) | 11.21% | 8.87% | 13.07% | 9.92% | 11.73% |
| Return on Invested Capital (ROIC) | 7.87% | 6.75% | 9.47% | 6.85% | 8.12% |
| Return on Tangible Assets | 5.98% | 5.62% | 7.76% | 5.93% | 6.94% |
| Earnings Yield | 6.64% | 8.27% | 9.87% | 7.20% | 9.66% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.56 | 2.51 | 2.91 | 2.62 | 2.66 |
| Payables Turnover | 4.61 | 3.19 | 3.63 | 3.16 | 3.81 |
| Inventory Turnover | 2.63 | 1.93 | 2.38 | 2.54 | 3.97 |
| Fixed Asset Turnover | 8.34 | 7.06 | 7.10 | 6.13 | 6.50 |
| Asset Turnover | 0.63 | 0.55 | 0.59 | 0.48 | 0.52 |
| Working Capital Turnover Ratio | 0.90 | 0.82 | 0.78 | 0.66 | 0.72 |
| Cash Conversion Cycle | 202.21 | 220.56 | 178.24 | 167.45 | 133.45 |
| Days of Sales Outstanding | 142.36 | 145.67 | 125.64 | 139.26 | 137.43 |
| Days of Inventory Outstanding | 138.98 | 189.25 | 153.28 | 143.74 | 91.91 |
| Days of Payables Outstanding | 79.13 | 114.36 | 100.68 | 115.54 | 95.89 |
| Operating Cycle | 281.34 | 334.92 | 278.92 | 282.99 | 229.35 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 159.55 | 141.17 | 146.60 | 105.13 | 242.86 |
| Free Cash Flow Per Share | 154.59 | 137.58 | 133.48 | 88.69 | 233.43 |
| Dividend Paid and CapEx Coverage Ratio | 2.18 | 1.97 | 1.87 | 1.38 | 4.01 |
| Capital Expenditure Coverage Ratio | 32.16 | 39.31 | 11.18 | 6.40 | 25.73 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.10 | 0.10 | 0.11 | 0.09 | 0.21 |
| Free Cash Flow Yield | 6.61% | 7.84% | 7.62% | 4.68% | 14.95% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 15.06 | 12.10 | 10.13 | 13.90 | 10.35 |
| Price-to-Sales (P/S) Ratio | 1.44 | 1.23 | 1.33 | 1.71 | 1.37 |
| Price-to-Book (P/B) Ratio | 1.12 | 0.84 | 0.99 | 0.98 | 0.85 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 15.13 | 12.76 | 13.13 | 21.37 | 6.69 |
| Price-to-Operating Cash Flow Ratio | 14.66 | 12.43 | 11.95 | 18.03 | 6.43 |
| Price-to-Earnings Growth (PEG) Ratio | 2.14 | -0.75 | 0.38 | -1.45 | 0.93 |
| Enterprise Value Multiple | 4.06 | 2.21 | 2.60 | 2.41 | 0.89 |
| Enterprise Value | 7.16B | 3.09B | 5.07B | 4.24B | 1.74B |
| EV to EBITDA | 4.06 | 2.21 | 2.60 | 2.41 | 0.89 |
| EV to Sales | 0.64 | 0.31 | 0.49 | 0.45 | 0.18 |
| EV to Free Cash Flow | 6.71 | 3.24 | 4.87 | 5.67 | 0.88 |
| EV to Operating Cash Flow | 6.50 | 3.16 | 4.44 | 4.78 | 0.84 |
| Tangible Book Value Per Share | 2082.56 | 2069.36 | 1763.63 | 1938.89 | 1838.51 |
| Shareholders’ Equity Per Share | 2089.38 | 2077.99 | 1772.78 | 1941.61 | 1842.40 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.30 | 0.24 | 0.28 | 0.31 | 0.31 |
| Revenue Per Share | 1629.20 | 1430.55 | 1319.31 | 1109.93 | 1141.82 |
| Net Income Per Share | 155.28 | 145.08 | 172.95 | 136.35 | 150.85 |
| Tax Burden | 0.70 | 0.76 | 0.72 | 0.69 | 0.69 |
| Interest Burden | 0.91 | 1.01 | 1.01 | 1.01 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.07 | 0.05 | 0.04 | 0.04 |
| SG&A to Revenue | 0.32 | 0.29 | 0.01 | 0.01 | 0.01 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.03 | 0.97 | 0.85 | 0.53 | 1.11 |
Currency in JPY

